GenMont Biotech Inc (3164) — Net Asset Quality Index
GenMont Biotech Inc (3164) has a Net Asset Quality Index of 82.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$1.70 Billion minus total liabilities of NT$297.05 Million yields net assets of NT$1.41 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 3164 total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
GenMont Biotech Inc Net Asset Quality Index Over Time (2003–2025)
This chart shows how GenMont Biotech Inc's Net Asset Quality Index has evolved across 23 annual periods from 2003 to 2025. As of March 2026, the index stands at 82.6%, representing net assets of NT$1.41 Billion against total assets of NT$1.70 Billion TWD. For live market cap and overall valuation, see GenMont Biotech Inc (3164) total market value.
Annual Net Asset Quality Index for GenMont Biotech Inc (2003–2025)
The table below presents the year-by-year Net Asset Quality Index for GenMont Biotech Inc from 2003 to 2025, covering 23 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 3164 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.1% | NT$1.45 Billion | NT$1.67 Billion | NT$215.35 Million | ▲ +0.5 pp |
| 2024 | 86.6% | NT$1.48 Billion | NT$1.71 Billion | NT$229.06 Million | ▼ -1.1 pp |
| 2023 | 87.7% | NT$1.45 Billion | NT$1.65 Billion | NT$204.06 Million | ▼ -0.6 pp |
| 2022 | 88.3% | NT$1.50 Billion | NT$1.70 Billion | NT$198.59 Million | ▼ -1.5 pp |
| 2021 | 89.8% | NT$1.52 Billion | NT$1.70 Billion | NT$173.65 Million | ▼ -2.1 pp |
| 2020 | 91.9% | NT$1.48 Billion | NT$1.61 Billion | NT$130.95 Million | ▼ -0.3 pp |
| 2019 | 92.2% | NT$1.45 Billion | NT$1.57 Billion | NT$123.04 Million | ▼ -2.1 pp |
| 2018 | 94.2% | NT$1.56 Billion | NT$1.66 Billion | NT$95.60 Million | ▲ +2.9 pp |
| 2017 | 91.4% | NT$1.37 Billion | NT$1.50 Billion | NT$129.41 Million | ▲ +0.2 pp |
| 2016 | 91.2% | NT$1.28 Billion | NT$1.40 Billion | NT$124.14 Million | ▼ -0.7 pp |
| 2015 | 91.8% | NT$1.50 Billion | NT$1.63 Billion | NT$133.43 Million | ▲ +0.1 pp |
| 2014 | 91.7% | NT$1.60 Billion | NT$1.74 Billion | NT$144.76 Million | ▲ +30.7 pp |
| 2013 | 60.9% | NT$837.28 Million | NT$1.37 Billion | NT$536.49 Million | ▲ +0.6 pp |
| 2012 | 60.3% | NT$861.62 Million | NT$1.43 Billion | NT$566.61 Million | ▼ -0.3 pp |
| 2011 | 60.6% | NT$904.75 Million | NT$1.49 Billion | NT$588.06 Million | ▲ +6.6 pp |
| 2010 | 54.0% | NT$737.87 Million | NT$1.37 Billion | NT$627.66 Million | ▼ -33.8 pp |
| 2009 | 87.8% | NT$635.68 Million | NT$724.10 Million | NT$88.42 Million | ▼ -1.7 pp |
| 2008 | 89.5% | NT$609.60 Million | NT$680.96 Million | NT$71.36 Million | ▼ -2.3 pp |
| 2007 | 91.8% | NT$524.64 Million | NT$571.68 Million | NT$47.04 Million | ▲ +3.1 pp |
| 2006 | 88.6% | NT$461.75 Million | NT$520.93 Million | NT$59.18 Million | ▼ -3.9 pp |
| 2005 | 92.5% | NT$290.14 Million | NT$313.55 Million | NT$23.41 Million | ▼ -2.6 pp |
| 2004 | 95.2% | NT$294.16 Million | NT$309.07 Million | NT$14.91 Million | ▼ -1.1 pp |
| 2003 | 96.3% | NT$248.64 Million | NT$258.26 Million | NT$9.62 Million | — |